EWTX- Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. (EWTX) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 525.0K | $19.33M | - | |
| CFO | 262.5K | $9.66M | - | |
| Other | 180.0K | $6.63M | - | |
| Other | 161.3K | $5.94M | - | |
| Other | 123.4K | $4.54M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | Donovan Joanne M.49 | CMO | Sale+OE | 55,230 | $37.88 | $2,092,062.91 | -86.3% | - | - | |
| Mar 31, 2026 | Donovan Joanne M.49 | CMO | Sale+OE | 21,338 | $32.12 | $685,308.28 | -69.0% | - | - | |
| Mar 27, 2026 | Donovan Joanne M.49 | CMO | Sell | 16,358 | $30.98 | $506,734.85 | -38.7% | - | - | |
| Nov 12, 2025 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 100,000 | $21.12 | $2,112,450.00 | -81.0% | +46.4% | - | |
| Nov 11, 2025 | Fox Jonathan C | - | Buy | 10,700 | $18.64 | $199,403.06 | +82.3% | +40.8% | - | |
| Aug 26, 2025 | Russell Alan J77 | Chief Scientific Officer | Sale+OE | 100,000 | $14.60 | $1,459,760.00 | -81.0% | +60.8% | - | |
| Aug 12, 2025 | Moore John R45 | General Counsel | Sale+OE | 2,098 | $13.39 | $28,097.26 | -17.0% | +36.5% | - | |
| Aug 12, 2025 | Derakhshan Behrad52 | Chief Business Officer | Sale+OE | 2,491 | $13.39 | $33,360.47 | -9.5% | +36.5% | - | |
| Aug 12, 2025 | Carruthers R Michael48 | Chief Financial Officer | Sale+OE | 1,428 | $13.39 | $19,124.35 | -1.6% | +36.5% | - | |
| Aug 12, 2025 | Koch Kevin55 | President And CEO | Sale+OE | 7,972 | $13.39 | $106,764.21 | -20.7% | +36.5% | - |
Page 1Next →